Hang Seng Index Extends Late-Session Gains, Closes Up Over 1%

The move is notable less for its size than for its composition: gains led by Chinese pharmaceutical names suggest stock-specific catalysts or sector rotation rather than broad risk appetite returning to Hong Kong. That distinction matters for anyone tracking whether mainland-linked healthcare is decoupling from the wider index. The open question is whether pharma leadership persists or proves a one-session rotation, but with no volume, breadth or driver disclosed, the signal value is limited.